Christopher Peetz, CHIEF EXECUTIVE OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), sold 30,000 shares at $98.08 ($3.0M) on 2026-09-01, disclosed to the SEC on 2026-09-03.
Scheduled sale ($3.0M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.08 | 8,312 | $815K | 27.5% |
| 2 | $98.91 | 21,688 | $2.1M | 72.5% |
| Total | $98.68 avg | 30,000 | $3.0M | 100% |
| Filing → |
| MIRM | SELL | 2026-06-02 | $2.9M | — | Filing → |
| MIRM | SELL | 2026-03-17 | $7.5M | — | Filing → |
| MIRM | SELL | 2026-02-03 | $941K | — | Filing → |